Vijaya Atluru
Neurology with Special Qualifications in Child Neurology · Bethpage, NYNPI 1699712521
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,450 of the $16,806 with a category attached, or 62.2%. Supernus Pharmaceuticals, Inc. accounts for 74.9% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $12,865, more than ten times the $1,044 reported in 2019. Among neurology with special qualifications in child neurology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $236.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$13K
- UCB, Inc.$978
- Eisai Inc.$777
- GSK$496
- Abbott$325
- Abiomed$146
- plus $1K from 17 others
Across 11 payments — averaging $5814.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biohaven Pharmaceutical Holding Company Ltd.$35K
- Pfizer$29K
What the payments were for
- Speaking & faculty fees$10,45062%
- Travel & lodging$1,3368%
- Food & beverage$5,01930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 21 | $12,591 |
| UCB, Inc. | 14 | $978 |
| Eisai Inc. | 8 | $777 |
| GSK | 5 | $496 |
| Abbott | 2 | $325 |
| Abiomed | 1 | $146 |
| 4web, Inc. | 1 | $135 |
| Medtronic | 1 | $125 |
| Ironshore Pharmaceuticals Inc. | 1 | $125 |
| Insmed, Inc. | 1 | $121 |
| Boston Scientific | 3 | $120 |
| Biomarin Pharmaceutical Inc. | 1 | $119 |
| Biogen | 1 | $112 |
| SK Life Science, Inc. | 1 | $106 |
| Impel Pharmaceuticals Inc. | 1 | $98 |
| Neurelis, Inc. | 1 | $97 |
| Lundbeck LLC | 1 | $91 |
| Jazz Pharmaceuticals Inc. | 1 | $66 |
| Acadia Pharmaceuticals Inc | 1 | $57 |
| Genentech USA, Inc. | 1 | $41 |
| Neos Therapeutics, LP | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$12,147
- Fycompa$746
- SHINGRIX$250
- XIENCE SIERRA$175
- FREESTYLE LIBRE 3$150
- Impella$146
- SPINE TRUSS SYSTEM$135
- ONYX FRONTIER$125
- Fintepla$125
- Briviact$125
- JORNAY PM$125
- BEXSERO$122
- Nayzilam$122
- Brineura$119
- SPINRAZA$112
- XCOPRI$106
How this compares
$16,806 in reported general payments places this provider in the 90th percentile of 161 neurology with special qualifications in child neurology providers in New York.
See all neurology with special qualifications in child neurology providers in New York →
Other neurology with special qualifications in child neurology in Bethpage
- Claudia ChiribogaNew York$220K
- Eric SegalN White Plains$133K
- Kaleb YohayNew York$125K
- Heather LauNew York$103K
- Louis ManganasEast Setauket$86K
- Darryl DevivoNew York$67K
- Mary Lynn ChuNew York$66K
- Jonathan MinkRochester$54K
- Sanjeev KothareNew Hyde Park$53K
- Mohammad QasaymehAmherst$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.